Demser

Active Ingredient(s): Metyrosine
FDA Approved: * October 3, 1979
Pharm Company: * MERCK
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Demser Overview

Metirosine (INN and BAN; α-Methyltyrosine, Metyrosine USAN, AMPT) is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis, which, as a consequence, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body. Clinical use Metirosine has been shown to suppress catecholamine synthesis and alleviate symptoms related to catecholamine excess, including hypertension, headache, tachycardia, constipation...

Read more Demser Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Metirosine

Recent Demser Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Demser: (1 result)

Sorted by National Drug Code

• 25010-305 Demser 250 mg Oral Capsule by Aton Pharma, Inc.

Other drugs which contain Metyrosine or a similar ingredient: (1 result)

• METYROSINE